We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUG INDUSTRY'S PRICING MODEL UNDER ATTACK, CEI SAYS
DRUG INDUSTRY'S PRICING MODEL UNDER ATTACK, CEI SAYS
December 30, 2004
The primary methods of pricing drug products — through intellectual property rights and diversity pricing, which allows firms to charge higher prices to those with greater ability to pay — are under attack, says a free-market think tank in a new paper opposing drug importation proposals.